Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan To Announce Medical Device Reimbursement Cuts In Coming Weeks

This article was originally published in PharmAsia News

Executive Summary

Companies selling medical devices in Japan will be notified in the next few weeks of payment rate reductions for their products following the recent release of reimbursement rules for the 2010-2012 cycle

You may also be interested in...

AdvaMed Wary Of Japan's Ability To Improve Incremental Product Review

Japan is in need of device industry investment, but without the incentive of data exclusivity, the government needs to counter existing disincentives, says AdvaMed CEO.

SFDA Issues Revised GMP Draft Guideline Following Industry Comments; Expects Compliance To Come In Stages

SHANGHAI - Following industry comments, China's State FDA released another draft GMP guideline for which it seeks additional public comments. The revised draft offers clarity on a few key points but still leaves huge gaps that will need to be filled slowly over time

U.S. Medical Device, Diagnostics Firms Form Japan Business Lobby

TOKYO - A total of 62 U.S. medical device and diagnostics companies operating in Japan have founded a new business lobby in Japan, the American Medical Devices and Diagnostics Manufacturers' Association, the group announced April 14

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts